Preliminary study on CT contrast-enhanced radiomics for predicting central cervical lymph node status in patients with thyroid nodules

被引:2
|
作者
Kong, Dan [1 ]
Shan, Wenli [1 ]
Zhu, Yan [1 ]
Xu, Qingqing [1 ]
Duan, Shaofeng [2 ]
Guo, Lili [1 ]
机构
[1] Nanjing Med Univ, Dept Imaging, Affiliated Huaian 1 Peoples Hosp, Huaian, Jiangsu, Peoples R China
[2] GE Healthcare, Inst Precis Med, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
thyroid; cancer; lymph node; radiomics; x-ray computed tomography; contrast enhancement;
D O I
10.3389/fonc.2023.1060674
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo explore the feasibility of using a contrast-enhanced CT image-based radiomics model to predict central cervical lymph node status in patients with thyroid nodules. MethodsPretreatment clinical and CT imaging data from 271 patients with surgically diagnosed and treated thyroid nodules were retrospectively analyzed. According to the pathological features of the thyroid nodules and central lymph nodes, the patients were divided into three groups: group 1: papillary thyroid carcinoma (PTC) metastatic lymph node group; group 2: PTC nonmetastatic lymph node group; and group 3: benign thyroid nodule reactive lymph node group. Radiomics models were constructed to compare the three groups by pairwise classification (model 1: group 1 vs group 3; model 2: group 1 vs group 2; model 3: group 2 vs group 3; and model 4: group 1 vs groups (2 + 3)). The feature parameters with good generalizability and clinical risk factors were screened. A nomogram was constructed by combining the radiomics features and clinical risk factors. Receiver operating characteristic (ROC) curve, calibration curve and decision curve analysis (DCA) were performed to assess the diagnostic and clinical value of the nomogram. ResultsFor radiomics models 1, 2, and 3, the areas under the curve (AUCs) in the training group were 0.97, 0.96, and 0.93, respectively. The following independent clinical risk factors were identified: model 1, arterial phase CT values; model 2, sex and arterial phase CT values; model 3: none. The AUCs for the nomograms of models 1 and 2 in the training group were 0.98 and 0.97, respectively, and those in the test group were 0.95 and 0.87, respectively. The AUCs of the model 4 nomogram in the training and test groups were 0.96 and 0.94, respectively. Calibration curve analysis and DCA revealed the high clinical value of the nomograms of models 1, 2 and 4. ConclusionThe nomograms based on contrast-enhanced CT images had good predictive efficacy in classifying benign and malignant central cervical lymph nodes of thyroid nodule patients.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients—a radiomics nomogram analysis
    Xiaoyan Yang
    Min Liu
    Yanhong Ren
    Huang Chen
    Pengxin Yu
    Siyi Wang
    Rongguo Zhang
    Huaping Dai
    Chen Wang
    European Radiology, 2022, 32 : 2693 - 2703
  • [32] Dual-modal radiomics for predicting cervical lymph node metastasis in papillary thyroid carcinoma
    Ren, Yongzhen
    Lu, Siyuan
    Zhang, Dongmei
    Wang, Xian
    Agyekum, Enock Adjei
    Zhang, Jin
    Zhang, Qing
    Xu, Feiju
    Zhang, Guoliang
    Chen, Yu
    Shen, Xiangjun
    Zhang, Xuelin
    Wu, Ting
    Hu, Hui
    Shan, Xiuhong
    Wang, Jun
    Qian, Xiaoqin
    JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY, 2023, 31 (06) : 1263 - 1280
  • [33] Contrast-enhanced ultrasound image sequences based on radiomics analysis for diagnosis of metastatic cervical lymph nodes from thyroid cancer
    Zhao, Hai-Na
    Yin, Hao
    Li, Ming-Hao
    Zhang, He-Qing
    He, Yu-Shuang
    Luo, Hong-Hao
    Ma, Bu-Yun
    Ma, Lin
    Liu, Dong-Quan
    Peng, Yu-Lan
    GLAND SURGERY, 2024, 13 (08) : 1437 - 1447
  • [34] CT-based evaluation of axillary sentinel lymph node status in breast cancer: Value of added contrast-enhanced study
    Yuen, S
    Yamada, K
    Goto, M
    Sawai, K
    Nishimura, T
    ACTA RADIOLOGICA, 2004, 45 (07) : 730 - 737
  • [35] Utility of quantitative contrast-enhanced ultrasound for the prediction of lymph node metastasis in patients with papillary thyroid carcinoma
    Luo, Zhi-Yan
    Hong, Yu-Rong
    Yan, Cao-Xin
    Wang, Yong
    Ye, Qin
    Huang, Pintong
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2022, 80 (01) : 37 - 48
  • [36] Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma
    Barranger, E
    Darai, E
    CANCER, 2004, 101 (08) : 1919 - 1920
  • [37] Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma
    Marchiolè, P
    Buénerd, A
    Scoazec, JY
    Dargent, D
    Mathevet, P
    CANCER, 2004, 100 (10) : 2154 - 2159
  • [38] Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis
    Yang, Xiaoyan
    Liu, Min
    Ren, Yanhong
    Chen, Huang
    Yu, Pengxin
    Wang, Siyi
    Zhang, Rongguo
    Dai, Huaping
    Wang, Chen
    EUROPEAN RADIOLOGY, 2022, 32 (04) : 2693 - 2703
  • [39] Quantitative parameters of contrast-enhanced ultrasound effectively promote the prediction of cervical lymph node metastasis in papillary thyroid carcinoma
    Su, Biao
    Li, Lisha
    Liu, Yingchun
    Liu, Hui
    Zhan, Jia
    Chai, Qiliang
    Fang, Liang
    Wang, Ling
    Chen, Lin
    DRUG DISCOVERIES AND THERAPEUTICS, 2024, 18 (01): : 44 - 53
  • [40] Intra- and Peritumoral Radiomics of Contrast-Enhanced Mammography Predicts Axillary Lymph Node Metastasis in Patients With Breast Cancer: A Multicenter Study
    Wang, Zhongyi
    Zhang, Haicheng
    Lin, Fan
    Zhang, Ran
    Ma, Heng
    Shi, Yinghong
    Yang, Ping
    Zhang, Kun
    Zhao, Feng
    Mao, Ning
    Xie, Haizhu
    ACADEMIC RADIOLOGY, 2023, 30 : S133 - S142